J B CHEMICALS AND PHARMA (JBCHEPHARM) financials

J B CHEMICALS AND PHARMA (JBCHEPHARM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.[1]

Market Cap: ₹38,677Cr.
Current Price: ₹2,409
Stock P/E: 56.6
ROE: 18.4%
ROCE: 24.8%
Book Value: ₹251
Dividend Yield: 0.91%
52W High / Low: ₹2,526/1,672

In Mar 2026, J B CHEMICALS AND PHARMA (JBCHEPHARM) reported sales ₹836 Cr and net profit ₹97 Cr.

Annual Mar 2026: sales ₹3,890 Cr, net profit ₹674 Cr.

Shareholding: Promoters 48.80% (Mar 2026), FIIs 16.33% (Mar 2026), DIIs 21.38% (Mar 2026), Government 0.00% (Mar 2026), Public 13.48% (Mar 2026).

JBCHEPHARM quarterly results (₹ Cr.)
Category	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	952	956	914	901	1,040	1,023	991	836
Expenses	679	688	668	670	747	724	721	642
Operating Profit	273	268	245	231	293	298	270	195
OPM %	29%	28%	27%	26%	28%	29%	27%	23%
Other Income	5	9	7	14	14	14	17	-17
Interest	4	2	2	1	1	1	2	1
Depreciation	40	41	41	44	41	43	44	49
Profit before tax	234	234	210	199	265	268	241	128
Tax %	26%	26%	25%	25%	25%	25%	26%	25%
Net Profit	173	173	156	150	198	200	179	97
EPS in Rs	11.16	11.15	10.06	9.62	12.68	12.80	11.44	6.01
Raw PDF	—	—	—	—	—	—	—	—

JBCHEPHARM profit and loss (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	1,501	1,641	1,892	2,190	2,884	3,299	3,723	3,890
Expenses	1,209	1,270	1,340	1,681	2,219	2,419	2,705	2,834
Operating Profit	292	370	552	509	665	880	1,018	1,056
OPM %	19%	23%	29%	23%	23%	27%	27%	27%
Other Income	37	37	116	39	9	34	35	28
Interest	5	3	7	5	34	41	9	5
Depreciation	55	65	67	71	112	135	166	177
Profit before tax	269	340	594	471	527	738	877	903
Tax %	32%	21%	25%	23%	26%	26%	26%	25%
Net Profit	182	268	447	361	389	543	653	674
EPS in Rs	11.35	17.34	28.92	23.35	25.12	35.01	41.91	41.97
Dividend Payout %	22%	32%	29%	35%	35%	35%	37%	52%

JBCHEPHARM balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	15	15	15	15	16	16	16
Reserves	1,469	1,430	1,791	2,088	2,427	2,871	3,362	4,022
Borrowings	26	29	39	52	547	359	12	3
Other Liabilities	283	337	355	382	480	668	788	783
Total Liabilities	1,793	1,811	2,200	2,538	3,470	3,914	4,178	4,823
Fixed Assets	552	583	565	1,204	1,822	1,925	1,883	1,796
CWIP	15	16	26	19	55	76	62	74
Investments	589	536	811	146	339	531	488	908
Other Assets	636	676	799	1,170	1,254	1,381	1,745	2,045
Total Assets	1,793	1,811	2,200	2,538	3,470	3,914	4,178	4,823

JBCHEPHARM cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	193	272	335	147	629	789	884	645
Cash from Investing Activity	-28	24	-231	4	-956	-412	-290	-587
Cash from Financing Activity	-156	-305	-87	-138	343	-374	-574	-108
Net Cash Flow	9	-10	18	13	16	2	20	-50
Free Cash Flow	152	203	336	-550	-128	532	774	566
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	87%	97%	86%	54%	108%	104%	106%	84%

JBCHEPHARM shareholding pattern (%)
Category	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	53.77%	53.74%	53.66%	47.84%	47.73%	47.56%	47.55%	48.80%
FIIs	12.17%	13.63%	14.64%	18.30%	17.77%	15.31%	14.88%	16.33%
DIIs	17.61%	16.81%	16.40%	18.71%	19.62%	22.83%	23.35%	21.38%
Government	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	16.42%	15.80%	15.29%	15.13%	14.87%	14.31%	14.21%	13.48%
No. of Shareholders	66,953	62,743	62,081	63,948	70,064	71,957	69,338	74,043

JBCHEPHARM key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	73	77	72	86	66	69	75	67
Inventory Days	142	149	163	172	136	152	137	193
Days Payable	76	97	96	96	78	109	112	111
Cash Conversion Cycle	139	128	139	162	124	112	101	148
Working Capital Days	92	82	89	124	81	52	77	127
ROCE %	17%	22%	32%	22%	22%	24%	26%	25%

JBCHEPHARMUpdated 19 Oct 2026, 5:39

J B Chemicals And Pharma

JBCHEPHARMUpdated 19 Oct 2026, 5:39

Market Cap

₹38,677Cr.

Current Price

₹2,409

High / Low

₹2,526/1,672

Stock P/E

56.6

ROE18.4%

ROCE24.8%

Book Value₹251

Face Value₹1.00

Dividend Yield0.91%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2023	699	12	538	3	31	122	27	89	5.73
Jun 2023	853	11	618	5	31	198	27	145	9.34
Sep 2023	837	9	602	7	32	201	28	145	9.36
Dec 2023	800	12	585	7	33	176	27	128	8.25
Mar 2024	809	8	614	16	40	163	23	126	8.11
Jun 2024	952	4	679	5	40	234	26	173	11.16
Sep 2024	956	2	688	9	41	234	26	173	11.15
Dec 2024	914	2	668	7	41	210	25	156	10.06
Mar 2025	901	1	670	14	44	199	25	150	9.62
Jun 2025	1040	1	747	14	41	265	25	198	12.68
Sep 2025	1023	1	724	14	43	268	25	200	12.8
Dec 2025	991	2	721	17	44	241	26	179	11.44
Mar 2026	836	1	642	-17	49	128	25	97	6.01

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	1061	7	868	10	38	159	29	114	6.7
Mar 2016	1144	10	917	55	40	231	22	179	10.57
Mar 2017	1175	5	952	46	46	217	20	173	10.2
Mar 2018	1250	3	1050	39	56	179	29	128	7.66
Mar 2019	1501	5	1209	37	55	269	32	182	11.35
Mar 2020	1641	3	1270	37	65	340	21	268	17.34
Mar 2021	1892	7	1340	116	67	594	25	447	28.92
Mar 2022	2190	5	1681	39	71	471	23	361	23.35
Mar 2023	2884	34	2219	9	112	527	26	389	25.12
Mar 2024	3299	41	2419	34	135	738	26	543	35.01
Mar 2025	3723	9	2705	35	166	877	26	653	41.91
Mar 2026	3890	5	2834	28	177	903	25	674	41.97

Shareholding pattern

As of Mar 2026%

Holder	Share
Promoters	48.8%
FIIs	16.33%
DIIs	21.38%
Public	13.48%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Jun 2023	53.91%	9.53%	18.65%	0%	17.9%
Sep 2023	53.86%	10.05%	18.58%	0%	17.5%
Dec 2023	53.83%	10.35%	18.53%	0%	17.27%
Mar 2024	53.78%	11.06%	18.38%	0.01%	16.78%
Jun 2024	53.77%	12.17%	17.61%	0%	16.42%
Sep 2024	53.74%	13.63%	16.81%	0.01%	15.8%
Dec 2024	53.66%	14.64%	16.4%	0%	15.29%
Mar 2025	47.84%	18.3%	18.71%	0%	15.13%
Jun 2025	47.73%	17.77%	19.62%	0%	14.87%
Sep 2025	47.56%	15.31%	22.83%	0%	14.31%
Dec 2025	47.55%	14.88%	23.35%	0%	14.21%
Mar 2026	48.8%	16.33%	21.38%	0%	13.48%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	17	999	105	327	1449	301	55	598	495	1449
Mar 2016	17	1206	175	244	1641	369	135	612	525	1641
Mar 2017	17	1371	49	248	1684	609	4	544	528	1684
Mar 2018	17	1437	28	285	1767	570	17	567	613	1767
Mar 2019	16	1469	26	283	1793	552	15	589	636	1793
Mar 2020	15	1430	29	337	1811	583	16	536	676	1811
Mar 2021	15	1791	39	355	2200	565	26	811	799	2200
Mar 2022	15	2088	52	382	2538	1204	19	146	1170	2538
Mar 2023	15	2427	547	480	3470	1822	55	339	1254	3470
Mar 2024	16	2871	359	668	3914	1925	76	531	1381	3914
Mar 2025	16	3362	12	788	4178	1883	62	488	1745	4178
Mar 2026	16	4022	3	783	4823	1796	74	908	2045	4823

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	143	-122	-23	-2
Mar 2016	171	-52	-97	22
Mar 2017	178	-42	-165	-30
Mar 2018	116	-24	-59	32
Mar 2019	193	-28	-156	9
Mar 2020	272	24	-305	-10
Mar 2021	335	-231	-87	18
Mar 2022	147	4	-138	13
Mar 2023	629	-956	343	16
Mar 2024	789	-412	-374	2
Mar 2025	884	-290	-574	20
Mar 2026	645	-587	-108	-50

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	85	85	82	88	73	77	72	86	66	69	75	67
Inventory Days	109	108	131	134	142	149	163	172	136	152	137	193
Days Payable	53	56	65	76	76	97	96	96	78	109	112	111
Cash Conversion Cycle	141	137	149	145	139	128	139	162	124	112	101	148
Working Capital Days	24	38	80	98	92	82	89	124	81	52	77	127
ROCE %	14%	17%	12%	9%	17%	22%	32%	22%	22%	24%	26%	25%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of J B CHEMICALS AND PHARMA (JBCHEPHARM)?

The reported market capitalisation for J B CHEMICALS AND PHARMA (JBCHEPHARM) is ₹38,677Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of JBCHEPHARM?

The current price shown for J B CHEMICALS AND PHARMA (JBCHEPHARM) on Fincrux is ₹2,409 with a 52-week high/low of ₹2,526/1,672.

What is the P/E ratio of J B CHEMICALS AND PHARMA (JBCHEPHARM)?

The stock P/E for J B CHEMICALS AND PHARMA (JBCHEPHARM) is 56.6 on Fincrux, with ROE at 18.4% and ROCE at 24.8%.

What were JBCHEPHARM latest quarterly results?

For Mar 2026, J B CHEMICALS AND PHARMA (JBCHEPHARM) reported sales ₹836 Cr and net profit ₹97 Cr (figures in ₹ crore unless noted).

What are JBCHEPHARM annual sales and net profit?

For Mar 2026, J B CHEMICALS AND PHARMA (JBCHEPHARM) shows sales of ₹3,890 Cr and net profit of ₹674 Cr on the Fincrux profit & loss statement.

Who owns J B CHEMICALS AND PHARMA (JBCHEPHARM)?

Latest shareholding for J B CHEMICALS AND PHARMA (JBCHEPHARM) on Fincrux: Promoters 48.80% (Mar 2026), FIIs 16.33% (Mar 2026), DIIs 21.38% (Mar 2026), Government 0.00% (Mar 2026), Public 13.48% (Mar 2026).

Where can I find J B CHEMICALS AND PHARMA (JBCHEPHARM) financials?

J B CHEMICALS AND PHARMA (JBCHEPHARM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show JBCHEPHARM balance sheet and cash flow?

Yes. The J B CHEMICALS AND PHARMA (JBCHEPHARM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 5:39